NTLA ▼ -6.0% - Intellia Therapeutics, Inc.
$NTLA - Intellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026
12-NOV-2026 10:00 AM ET
Share this post
More filings for $NTLA
NTLA - Intellia Therapeutics, Inc. - SEC Filing Update (10-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 10, 2026NTLA ▲ +0.1% - Intellia Therapeutics, Inc.Nov 10, 2026NTLA ▼ -3.7% - Intellia Therapeutics, Inc.Nov 5, 2026NTLA ▲ +2.4% - Intellia Therapeutics, Inc.Nov 4, 2026NTLA ▲ +1.9% - Intellia Therapeutics, Inc.Nov 3, 2026NTLA ▼ -2.7% - Intellia Therapeutics, Inc.Oct 29, 2026
View full $NTLA filing history →💬 Comments
Loading comments…
Leave a comment